Overview
- A JAMA analysis published Oct. 15 estimated that using a 300 ng/dL cutoff about 25.7% of active‑duty male Army personnel—roughly 100,691 soldiers—would have a single morning testosterone result below that threshold.
- The Pentagon announced in July a policy requiring annual screening for men 30 and older, and Defense Health Agency guidance requires two separate early‑morning tests before a diagnosis and makes treatment voluntary.
- Researchers and clinicians say a single low morning value does not diagnose hypogonadism because levels vary with time of day, sleep, illness, stress and body mass index, so many initial positives will need repeat testing and clinical evaluation.
- Retired military medical leaders and service members warned that broad screening could cause overdiagnosis, push long‑term testosterone therapy with fertility and clotting risks, complicate deployments where testosterone is a controlled drug, and strain military clinics.
- Using a lower CDC‑harmonized cutoff (264 ng/dL) would reduce the estimated number flagged to about 14.7% (≈57,788), and experts note that civilian guidelines normally test only symptomatic men, highlighting a divergence between routine screening and standard practice.